NCT04936217

Brief Summary

Continent Cutaneous Urinary Deviation (CUD), using the Mitrofanoff, Yang-Monti or Casale principle, is offered to patients with neurological diseases who are unable to perform intermittent catheterisation through the native urethra due to upper limb disability. There is very little data in the literature examining the long-term efficacy and complications of this technique. The main objective of this study is to evaluate the effectiveness of long-term CUDs in spinal cord injury patients. The secondary objectives are to evaluate the surgical complications and the impact on the patient's quality of life. For each patient, several data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly and any immediate or late complications. In a second stage, a questionnaire survey will be conducted by telephone.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 23, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

September 28, 2022

Status Verified

September 1, 2022

Enrollment Period

2.4 years

First QC Date

June 18, 2021

Last Update Submit

September 27, 2022

Conditions

Keywords

intermittent catheterizationMitrofanoffYang-Monti

Outcome Measures

Primary Outcomes (2)

  • Efficacy of continent cutaneous urinary derivation: catheterisation.

    The minimum frequency of urinary catheterisation in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.

    3 -16 years after their operation

  • Efficacy of continent cutaneous urinary derivation:leakage

    Absence of leakage through the cystostomy in spinal injured patients equipped with a continent cutaneous urinary derivation will be recorded.

    3 -16 years after their operation

Secondary Outcomes (13)

  • Surgical complications and impact on the patient's quality of life: Age at start of care

    3 -16 years after their operation

  • Surgical complications and impact on the patient's quality of life: Sex

    3 -16 years after their operation

  • Surgical complications and impact on the patient's quality of life: Body Mass Index

    3 -16 years after their operation

  • Surgical complications and impact on the patient's quality of life: ASA score

    3 -16 years after their operation

  • Surgical complications and impact on the patient's quality of life: ASIA score

    3 -16 years after their operation

  • +8 more secondary outcomes

Study Arms (1)

Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017

The study focuses of a population of 70 patients operated between April 2004 and October 2017 au Nîmes University Hospital for Cutaneous Urinary Diversion.

Other: Data collectionOther: Interview using a validated questionnaire

Interventions

For each patient, the following data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly, immediate and later complications.

Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017

A telephone survey will be conducted by means of a questionnaire in order to evaluate the patient's quality of life.

Patients operated for Continent Cutaneous Urinary Diversion, April 2004 - October 2017

Eligibility Criteria

Age17 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who have suffered a spinal cord injury, operated on between April 2004 and October 2017 at Nîmes University Hospital.

You may qualify if:

  • no history of continuous cystostomy in another centre
  • a follow-up \> 24 months,
  • a continent cutaneous urinary diversion for a spinal cord injury.
  • Patient affiliated to or beneficiary of a health insurance scheme.
  • Adult patient (≥18 years of age) and under 85 years of age.

You may not qualify if:

  • All urinary incontinence outside of medullary waiting period.
  • A history of continuous cystostomy in another centre.
  • A follow-up of less than 24 months,
  • a continent cutaneous urinary diversion for a neurological pathology other than spinal cord injury.
  • Patient for whom it is impossible to give enlightened information.
  • Patient under legal protection, guardianship or curatorship.
  • Patient unable to express consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nîmes University Hospital

Nîmes, Gard, 30029, France

RECRUITING

MeSH Terms

Conditions

Spinal Cord InjuriesUrinary Bladder, Neurogenic

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesNeurologic ManifestationsUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2021

First Posted

June 23, 2021

Study Start

August 1, 2020

Primary Completion

January 1, 2023

Study Completion

June 1, 2023

Last Updated

September 28, 2022

Record last verified: 2022-09

Locations